Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
| Author | Biao Yang | en |
| Author | Xin You | en |
| Author | Min lan Yuan | en |
| Author | Tian Qiang Qin | en |
| Author | Lin Jia Duan | en |
| Author | Jiao He | en |
| Author | Ze Jun Fei | en |
| Author | Xuan Zhou | en |
| Author | Rui Yu Zan | en |
| Author | Zheng Yin Liao | en |
| Issued Date | 2016-08-01 | en |
| Abstract | Background: The prognosis for hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is extremely poor. Objectives: This study aimed to evaluate the safety and effectiveness of transarterial ethanol ablation (TEA) for the treatment of HCC with PVTT. Methods: Patients were treated with TEA for PVTT under cone-beam computed tomography and traditional transarterial chemoembolization (TACE) with epirubicin for intrahepatic lesions. Results: Seventeen men were successfully treated with TACE plus TEA. The mean overall survival was 18.3 ± 9.0 months (95% CI: 13.7 - 3.0 months). The quality of life (QoL) score increased from 56.9 ± 15.7 before the procedure to 88.5 ± 11.7 at 4 weeks after the procedure. Lipiodol accumulation grades of 3, 2, 1, and 0 were obtained in 3 (17.6%), 8 (47.1%), 6 (35.3%), and 0 (0%) patients, respectively. Conclusions: TEA is a safe and effective method for treating patients with PVTT, offering advantages for QoL, response rate after TEA, and OS. | en |
| DOI | https://doi.org/10.5812/hepatmon.37584 | en |
| Keyword | Portal Vein Tumor Thrombosis | en |
| Keyword | Ethanol | en |
| Keyword | Transarterial Ethanol Ablation | en |
| Keyword | Hepatocellular Carcinoma | en |
| Keyword | Cone-Beam Computed Tomography | en |
| Publisher | Brieflands | en |
| Title | Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus | en |
| Type | Research Article | en |